Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Artificial support systems for liver failure

P D Berk, B F Scharschmidt, J F Martin

    Kidney International. Supplement
    |December 1, 1976
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Urinary phenylacetylglutamine (U-PAGN) concentration as biomarker for adherence in patients with urea cycle disorders (UCD) treated with glycerol phenylbutyrate.

    Molecular genetics and metabolism reports·2017
    Same author

    Overt hepatic encephalopathy: development of a novel clinician reported outcome tool and electronic caregiver diary.

    Metabolic brain disease·2016
    Same author

    Refeeding syndrome in a young woman with argininosuccinate lyase deficiency.

    Molecular genetics and metabolism reports·2016
    Same author

    Prospective Multicenter Observational Study of Overt Hepatic Encephalopathy.

    Digestive diseases and sciences·2016
    Same author

    Glutamine and hyperammonemic crises in patients with urea cycle disorders.

    Molecular genetics and metabolism·2015
    Same author

    Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio.

    Molecular genetics and metabolism·2013
    Same journal

    Effect of kidney disease on glucose handling (including genetic defects).

    Kidney international. Supplement·2011
    Same journal

    Need for better diabetes treatment for improved renal outcome.

    Kidney international. Supplement·2011
    Same journal

    Glucose dynamics and mechanistic implications of SGLT2 inhibitors in animals and humans.

    Kidney international. Supplement·2011
    Same journal

    SGLT2 inhibitors: molecular design and potential differences in effect.

    Kidney international. Supplement·2011
    Same journal

    Glucose handling by the kidney.

    Kidney international. Supplement·2011
    Same journal

    Bone: from a reservoir of minerals to a regulator of energy metabolism.

    Kidney international. Supplement·2011
    See all related articles